SCHEMBL3072792

SCHEMBL3072792

NC(=O)c1cccc(OCCCCl)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 9/20 0.58
▸ PARP1 P09874 2/20 0.57
▸ PARP10 Q53GL7 2/20 0.54
▸ TNKS O95271 1/20 0.54
▸ PARP15 Q460N3 1/20 0.54
▸ PARP14 Q460N5 1/20 0.54
▸ TNKS2 Q9H2K2 1/20 0.54
▸ PARP2 Q9UGN5 1/20 0.54
▸ F2 P00734 1/20 0.54
▸ PLG P00747 1/20 0.54
▸ PRSS2 P07478 1/20 0.54
▸ C1S P09871 1/20 0.54
▸ PRSS3 P35030 1/20 0.54
▸ HTR1A P08908 1/20 0.52
▸ DRD2 P14416 1/20 0.52
▸ HTR2A P28223 1/20 0.52
▸ KMT2A Q03164 1/20 0.51
▸ F10 P00742 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500784 0.93 PARP1 (0.57) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL9448432 0.87 PRSS1 (0.58) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL203431 0.87 PRSS1 (0.67) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL29686682 0.87 PRSS1 (0.58) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL27816266 0.86 PARP1 (0.61) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL3979585 0.85 PRSS1 (0.65) PRSS1PARP1PARP10F2PLG
SCHEMBL2704566 0.85 PRSS1 (0.57) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL203780 0.85 PRSS1 (0.61) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL201450 0.85 KMT2A (0.62) PRSS1PARP1PARP10TNKSPARP15
SCHEMBL9337589 0.85 KMT2A (0.71) PRSS1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 — — US claimed
EP-1866293-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2007-12-19 — — EP claimed
WO-2006103045-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA S.A. (BE) 2006-10-05 — — WO claimed
US-7790720-B2 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses UCB PHARMA, S.A. (BE) 2010-09-07 — — US disclosed
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 — — US disclosed
EP-1866293-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2007-12-19 — — EP disclosed
WO-2006103045-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA S.A. (BE) 2006-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses OXER1, OXTR, OGFR PRSS1 3959/4885PARP1 4350/4885PARP10 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback